Pan, H., Wang, J., Huang, J., Shuai, Y., Li, J., Hu, Z., . . . Liu, Q. (2020). Ranibizumab plus fufang xueshuantong capsule versus ranibizumab alone for exudative age-related macular degeneration. J Int Med Res.
Chicago Style CitationPan, Hai-Tao, Jun-Jun Wang, Jun-Long Huang, Yuan-Lu Shuai, Jia Li, Zi-Zhong Hu, Yu-Zhi Ding, and Qing-Huai Liu. "Ranibizumab Plus Fufang Xueshuantong Capsule Versus Ranibizumab Alone for Exudative Age-related Macular Degeneration." J Int Med Res 2020.
MLA CitationPan, Hai-Tao, et al. "Ranibizumab Plus Fufang Xueshuantong Capsule Versus Ranibizumab Alone for Exudative Age-related Macular Degeneration." J Int Med Res 2020.
Warning: These citations may not always be 100% accurate.